CDSCO Drug Alert: 48 drug samples flagged Not Of Standard Quality Dr. Divya Colin25 April 2023 6:00 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 48 medicine...
Submit complete safety data: CDSCO panel tells Novartis on Remibrutinib Dr. Divya Colin23 April 2023 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has recommended the drug maker...
Glenmark Gets CDSCO panel nod for Phase IV CT of COPD drug Dr. Divya Colin22 April 2023 5:45 PM ISTNew Delhi: Pharmaceutical major, Glenmark has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Akums gets CDSCO Panel nod for Phase III CT of FDC Moxifloxacin, Nepafenac ophthalmic solution Dr. Divya Colin19 April 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceutical has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Revise Phase I/II CT protocol: CDSCO panel tells Serum Institute of India on Dengue Tetravalent Vaccine Dr. Divya Colin17 April 2023 6:00 PM ISTNew Delhi: Regarding the Phase I/II clinical trial of Dengue Tetravalent Vaccine (Live, Attenuated), the Subject Expert Committee (SEC) functional...
J&J Gets CDSCO Panel Nod To Conduct Phase IV CT of Ustekinumab Dr. Divya Colin16 April 2023 5:45 PM ISTNew Delhi: In order to evaluate safety of Ustekinumab in Indian subjects with Crohn’s Disease (CD), pharmaceutical major, Johnson & Johnson has...
Present More Data On Almitrine, Ifenprodil: CDSCO Panel Tells CDRI-CSIR Dr. Divya Colin16 April 2023 5:30 PM ISTNew Delhi: After deliberating the Phase III clinical trial protocol of the pulmonary drug Almitrine and Ifenprodil, the Subject Expert Committee (SEC)...
Revise Phase III CT protocol: CDSCO Panel Tells Dr Reddy's over Tegoprazan Dr. Divya Colin15 April 2023 6:00 PM ISTNew Delhi: In response to the proposal to conduct a Phase III clinical trial presented by the drug major Reddy's Laboratories, the Subject Expert...
Revise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine with Yellow Fever Vaccine Dr. Divya Colin15 April 2023 5:15 PM ISTNew Delhi: In response to the drug major Zydus Life Sciences' proposal to conduct Phase IV clinical for Typhoid Vi Conjugate Vaccine I.P.(TCV) with...
CDSCO Panel Grants Abbott's Protocol Amendment Proposal For Ursodeoxycholic Acid Dr. Divya Colin15 April 2023 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has accepted Abbott's phase III...
CDSCO seeks details of 16 FDCs named as irrational for further examination Farhat Nasim13 April 2023 1:30 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a notice seeking all the manufacturers of the 16 Fixed Dose Combinations...
Lupin Gets CDSCO Panel Nod for Phase IV CT of pulmonary FDC drug Dr. Divya Colin11 April 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Lupin has got the go ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
